Skip to Main Content

Paper Details

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
Eur Urol
2
2024
Author NameAffiliation
Ronald de WitErasmus MC Cancer Institute
  • 1 - 1

Datasets

Release 1.2